Skip to content

Septic Pseudarthrosis Of Long Bone : Experience In A Regional Reference Center

Septic Pseudarthrosis Of Long Bone : Experience In A Regional Reference Center

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03620305
Enrollment
20
Registered
2018-08-08
Start date
2018-04-01
Completion date
2018-12-30
Last updated
2019-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pseudoarthrosis of Bone

Brief summary

Description of septic pseudarthrosis with chirurgical treatment in two steps (first step : Implementation of cement, second step : bone reconstruction, with or without device)

Interventions

OTHERDescription of treatment of septic pseudarthrosis

description of chirurgical 2 steps management of septic pseudarthrosis

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years

Inclusion criteria

* patients having septic pseudarthrosis of long bone treated at the CRIOAc LYON

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Description of treatment of septic pseudarthrosis : chirurgical treatment - rate of use of this type of chirurgical treatment among patients with septic pseudarthrosisOutcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)Description of treatment of septic pseudarthrosis : chirurgical treatment

Secondary

MeasureTime frameDescription
Description of treatment of septic pseudarthrosis : medical treatment - duration of treatment in patients having sepstic pseudarthrosisOutcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)Description of treatment of septic pseudarthrosis : medical treatment
Treatment failure : rate of failure with this 2 times chirurgical treatmentOutcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)Treatment failure is defined by local clinical and/or microbiological relapse; and/or need for additional surgery; death of septic origin

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026